Cardiovascular Outcomes with GLP-1 Receptor Agonists in Patients with Diabetes or Obesity Undergoing Transcatheter Aortic Valve Replacement

By afschroeder • April 23, 2026

Goyal A, Saeed H, Jain H, Hurjkaliani S, Mahalwar G, Jaiswal V, Ricciardi MJ, Kolte D, Fonarow GC, Piazza G, Kapadia S, Qamar A. Cardiovascular Outcomes with GLP-1 Receptor Agonists in Patients with Diabetes or Obesity Undergoing Transcatheter Aortic Valve Replacement. Can J Cardiol. 2026 Apr 20:S0828-282X(26)00358-2. doi: 10.1016/j.cjca.2026.04.003. Epub ahead of print. PMID: 42019817.

Tags: Cardiology/Epi, glp-1 ra, mortality, Outcomes, Publications, Structural, TAVR, transcatheter aortic valve replacement

Optimization of Image Quality for Quantitative Multicontrast Atherosclerosis Characterization (qMATCH): Comparison between Transverse and Coronal Acquisitions

Hsu YC, Lu M, Llanes A, Keushkerian MJ, Nguyen KL, Johnson K, Altbach MI, Morris HD, DeMarco JK, Deshpande V, Mitsouras D, Saloner D, McNally[...]

Serial Assessment of Patient-Reported Health Status and Subsequent Clinical Outcomes in Atrial Fibrillation

Shiraishi Y, Nakamaru R, Kohsaka S, Sandhu AT, Heidenreich PA, Ikemura N, Sawano M, Niimi N, Kimura T, Katsumata Y, Nishiyama T, Ueda I, Takatsuki[...]

Electrically functionalized body surface for deep-tissue bioelectrical recording

Zhang D, Zhao G, Zhang Y, Xu D, Wang S, Wang K, Zhou B, Ling Y, Liu Y, Cui Q, Yin J, Zhu E, Zhao[...]